Compare MRKR & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRKR | MLSS |
|---|---|---|
| Founded | N/A | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.0M | 20.8M |
| IPO Year | 2010 | 1996 |
| Metric | MRKR | MLSS |
|---|---|---|
| Price | $1.37 | $0.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $11.25 | $1.00 |
| AVG Volume (30 Days) | ★ 117.5K | 77.3K |
| Earning Date | 03-18-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.61 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $8,629,928.00 |
| Revenue This Year | N/A | $8.95 |
| Revenue Next Year | N/A | $7.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.81 | $0.22 |
| 52 Week High | $4.07 | $1.11 |
| Indicator | MRKR | MLSS |
|---|---|---|
| Relative Strength Index (RSI) | 42.58 | 51.20 |
| Support Level | $0.83 | $0.24 |
| Resistance Level | $1.44 | $0.30 |
| Average True Range (ATR) | 0.10 | 0.02 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 30.00 | 71.17 |
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.